𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of trimetrexate in untreated advanced gastric carcinoma

✍ Scribed by Alexander Hantel; Catherine M. Tangen; John S. Macdonald; Stephen P. Richman; Reginald P. Pugh; Theodore Pollock

Publisher
Springer US
Year
1994
Tongue
English
Weight
221 KB
Volume
12
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of trimetrexate for patie
Phase II trial of trimetrexate for patients with advanced gastric carcinoma : An Eastern Cooperative Oncology Group Study (E1287)
✍ Ramesh K. Ramanathan; Stuart Lipsitz; Robert F. Asbury; Raman Qazi; Bernard R. G πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 65 KB πŸ‘ 2 views

## BACKGROUND. A Phase II study was conducted to evaluate the response, duration of response, and duration of survival of patients with measurable gastric carcinoma treated with trimetrexate (TMTX) who had not had prior chemotherapy. ## METHODS. Thirty-three patients with unresectable or metast

An eastern cooperative oncology group ph
An eastern cooperative oncology group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma
✍ Robert S. Witte; Paul Elson; Janardan Khandakar; Donald L. Trump πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 359 KB πŸ‘ 2 views

## Background. Trimetrexate is an antifol that differs from methotrexate in ways that may be clinically important. Because methotrexate has activity in advanced bladder cancer, this trial was initiated.